Afeyan founded Flagship in 2000, building it into one of the world’s leading life science venture capital firms — often conceiving or incubating companies itself. Flagship has made numerous successful investments in recent years, among them Rubius Therapeutics, which bioengineers red blood cells to create new cellular therapies. But Flagship’s most notable success is Moderna, of which Afeyan is a co-founder and board chairman. In June 2021, Flagship raised $2.2 billion in its latest funding round.
From STAT:
Industry
Age
-
59
Location
-
Cambridge, MA
